Custom Protein Generation

Drug Substance Manufacturing

Drug Product Fill & Finish




Antibody Drug Conjugates

Technologies & Platforms

From Concept to Market - Unique Approaches in Biomanufacturing WuXi Biologics

From Concept to Market – Unique approaches in Biomanufacturing

Jincai Li, PhD, Vice President of WuXi Biologics

September 18 2019 | 78 mins

Access on-demand webinar here

Advanced process development using automated micro bioreactors shortens timelines and provides process solutions for a rapid scale up

Jincai Li, PhD, Vice President of WuXi Biologics; Liang Tang, PhD, Vice President of WuXi Biologics

September 14 2018 | 75 mins

Access on-demand webinar here


Strategies for Continuous Bioprocessing

Speakers: Weichang Zhou, Ph.D., Senior Vice President, Biologics Development and Manufacturing; Hang Zhou, Ph.D., Director of Cell Culture Process Development, WuXi Biologics

There has been a growing interest in continuous processing for biologics manufacturing. Compared to traditional batch technologies, continuous bioprocessing offers more flexibility and can improve product quality and lower the costs of production. This webinar will discuss:

  • The drivers behind the rising utilization of continuous bioprocessing technologies
  • The challenges in building an integrated continuous processing platform
  • The Strategies for developing an ATF™-based high density perfusion cell culture system and scaling-up from 2L to large scale
  • The solution for designing a continuous product capture unit operation

The webinar will conclude with a Q&A session.

Access on-demand webinar


New Process Development Workflow Shortens Timelines Enabling Rapid Scale Up

Speakers: Dr. Jincai Li , Vice President of Process Development, WuXi Biologics
Dr. Barney Zoro, Product Manager, Sartorius Stedim Biotech

In this webinar Dr Jincai Li will discuss how the new development workflow delivers accurate clone selection, powerful DOE optimisation and scaleup tools, improving predictions and reducing timelines. Dr Li will highlight how the ambr® 15 system works for a better clone selection and feeding / product quality studies; discuss how the ambr® 250 high throughput system accurately matches benchtop VCC, titre and metabolite profiles, and present on the fast, predictive scale up to production scale single use STR bioreactors.

Dr Barney Zoro, Product Manager at Sartorius Stedim Biotech, will provide a brief introduction and overview of the ambr® 15, ambr® 250 high throughput and Biostat® STR platforms .

Access on-demand webinar here.


Pioneering Approaches to Dismantling Cancer

Cancer continues to be a leading cause of morbidity and mortality worldwide with more than 8 million deaths and 14 million new cases per year. Significant advances have been made to unravel cancer’s mysteries and complexities at the genetic-, molecular- and pathway-levels. These advances not only reveal new scientific insights into the biology of the diseases, but also herald a new era with fresh perspectives for prevention, diagnosis, and more effective, precision-driven therapies. In this complimentary live webinar, open to life science professionals globally, WuXi brings together scientific and executive leaders from the pharma, biotech and the venture capital communities to discuss “Pioneering Approaches to Dismantling Cancer.”

Presenter: James Audia, CSO, Constellation Pharmaceuticals
Philip Gotwals, Executive Director, Exploratory Immuno-Oncology, Novartis Institutes of BioMedical Research
Jason Rhodes, Partner, Atlas Venture
Moderator: Richard Soll, SVP, International Discovery Service Unit, WuXi AppTec

Access on-demand webinar here.